AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Colgate-Palmolive reported Q1 results beating expectations, with net sales of $4.91 billion, a 3.1% decrease YoY, and organic sales growth of 1.4%. However, the company lowered its full-year guidance due to tariff concerns and currency pressures. Shares edged up to $95.25 but fell back, finishing down 2.18%. Analysts remain constructive on the stock but have adjusted their price targets downward.
Colgate-Palmolive (CL) reported its Q1 2025 earnings, beating market expectations with a Non-GAAP earnings per share (EPS) of $0.91, which exceeded estimates by $0.05 [1]. Despite a 3.1% decline in net sales to $4.91 billion, organic sales increased by 1.4% [2]. The company's earnings were driven by robust organic sales growth, volume, and pricing performance, as well as gross profit margin expansion. However, foreign exchange fluctuations negatively impacted total sales by 4.4%.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet